sLeX can serve as a ligand for cell surface-expressed E-selectin or P-selectin and is involved in selectin-mediated adhesion of cancer cells to the vascular endothelium, a critical step in the metastatic process (Kannagi et al. 2004). Here, SELE is linked to cancer.